shRNA-mediated knockdown of CXCR4 in vivo also proved that CXCR4 could increase glioma perivascular invasion and reduce radiation-induced apoptosis (Yadav et al., 2016). The gene discussed is CXCR4; the disease is central nervous system cancer.